Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
AnnexinV has been shown to bind phosphatidylserine expressed by chemotherapy-induced apoptotic cells increasing their immunogeneicity. Here, the authors demonstrate in a preclinical tumor model that fusing tumor-antigen peptide to Annexin V enhances its efficacy when administered after chemotherapy...
Guardado en:
Autores principales: | Tae Heung Kang, Jung Hwa Park, Andrew Yang, Hyun Jin Park, Sung Eun Lee, Young Seob Kim, Gun-Young Jang, Emily Farmer, Brandon Lam, Yeong-Min Park, Chien-Fu Hung |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2fb1fbb0de664cbdac06f9837a479b3c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Annexin A2 binds RNA and reduces the frameshifting efficiency of infectious bronchitis virus.
por: Hoyun Kwak, et al.
Publicado: (2011) -
Checkpoint inhibition through small molecule-induced internalization of programmed death-ligand 1
por: Jang-June Park, et al.
Publicado: (2021) -
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
por: Ju Yeon Lee, et al.
Publicado: (2016) -
Comparative Cell Biology and Evolution of Annexins in Diplomonads
por: Elin Einarsson, et al.
Publicado: (2016) -
Adhesion of annexin 7 deficient erythrocytes to endothelial cells.
por: Majed Abed, et al.
Publicado: (2013)